EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Highly expressed carbohydrate sulfotransferase 11 correlates with unfavorable prognosis and immune evasion of hepatocellular carcinoma

Dan-Dan Xiong, Jian-di Li, Rong-Quan He, Ming-Xuan Li, Yan-Qing Pan, Xiao-Lian He, Yi-Wu Dang, Gang Chen iD

Cancer Medicine · 2023-02 · 12 (4) · 4938-4950

DOI: 10.1002/cam4.5186 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, online erschienen am 05.09.2022. Verfasst von Dan-Dan Xiong und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, First Affiliated Hospital of Guangxi Medical University, Nanning, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite great advance has been made in multi‐modality treatments for HCC patients, the effectiveness is far from satisfactory with worse survival outcome, which may be partly explainable by the anti‐tumor deficiency of the immune system. It is necessary to clarify the molecular mechanism of HCC immunodeficiency. Here, we demonstrated that carbohydrate sulfotransferase 11 (CHST11) was upregulated in HCC and related to advanced TNM stage. HCC patients with TP53 mutation showed higher CHST11 expression. Survival analysis revealed that CHST11 was an independent prognostic biomarker in HCC. Cellular functional experiments indicated that knockdown of CHST11 in HCC inhibited cell proliferation and metastasis. Gene functional enrichment analyses indicated that CHST11 modulated pathways related to tumor growth, metastasis and immune regulation. Continuative immune‐related analyses revealed that CHST11 expression facilitated Tregs infiltration in HCC and promoted the expression of checkpoints PD‐L1/PD‐1, resulting in the immunosuppression of HCC. Targeting CHST11 may inhibit Tregs infiltration and enhance the antineoplastic effect of immune checkpoint inhibitors, which provides a novel insight into the combination immunotherapy with Treg‐modulating agents and PD‐L1/PD‐1 inhibitors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsHumansB7-H1 AntigenImmune EvasionPrognosisCarbohydrate Sulfotransferases

Stichwörter der Autor:innen

CHST11Treg cellshepatocellular carcinomaprognosis

Substanzen

B7-H1 AntigenCarbohydrate Sulfotransferases

Autor:innen und Institutionen

  • Department of Pathology, First Affiliated Hospital of Guangxi Medical University, Nanning, China.
  • Department of Medical Oncology, First Affiliated Hospital of Guangxi Medical University, Nanning, China.

ORCID-Profile: Gang Chen

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Xiong, D. D., Li, J. D., He, R. Q., Li, M. X., Pan, Y. Q., He, X. L., Dang, Y. W., & Chen, G. (2023). Highly expressed carbohydrate sulfotransferase 11 correlates with unfavorable prognosis and immune evasion of hepatocellular carcinoma. Cancer Medicine, 12(4), 4938-4950. https://doi.org/10.1002/cam4.5186

Vancouver

Xiong DD, Li JD, He RQ, Li MX, Pan YQ, He XL, et al. Highly expressed carbohydrate sulfotransferase 11 correlates with unfavorable prognosis and immune evasion of hepatocellular carcinoma. Cancer Medicine. 2023;12(4):4938-4950. doi:10.1002/cam4.5186

BibTeX
@article{Xiong2023,
  author = {Xiong, Dan-Dan and Li, Jian-di and He, Rong-Quan and Li, Ming-Xuan and Pan, Yan-Qing and He, Xiao-Lian and Dang, Yi-Wu and Chen, Gang},
  title = {Highly expressed carbohydrate sulfotransferase 11 correlates with unfavorable prognosis and immune evasion of hepatocellular carcinoma},
  journal = {Cancer Medicine},
  year = {2023},
  volume = {12},
  number = {4},
  pages = {4938--4950},
  doi = {10.1002/cam4.5186}
}
Kostenlos starten →